Exploring New Pathways for Industry Value: Registration Open for the 3rd China Digital Therapeutics Product Quality and Regulatory Symposium & 2024 Annual Meeting of the Digital Therapeutics Committee, China Association for Medical Devices

In 2024, the global healthcare industry once again faced unprecedented transformation and challenges. Under the combined pressures of economic fluctuations, population aging, and the rising prevalence of chronic diseases, traditional healthcare service models are undergoing unparalleled transformative strain. These challenges have not only affected the accessibility and quality of healthcare services but also posed new tests for the allocation and utilization of medical resources. Healthcare systems worldwide are seeking innovative solutions to address these evolving demands.

Against this backdrop, the digital health industry is demonstrating unique vitality and potential. Although many healthcare subsectors in China are experiencing slowed growth or even decline, digital health is regaining its value proposition by leveraging cutting-edge technologies such as artificial intelligence, cloud computing, the Internet of Things (IoT), and big data. With the in-depth implementation of the “Healthy China 2030” strategy, local governments across China are attaching unprecedented importance to and providing support for the digital transformation of the healthcare sector. Driven by policy incentives, coupled with China’s vast population base and growing health demands, the digital health industry is ushering in a trillion-yuan market poised for intelligent upgrading. While rapid technological advancements have introduced regulatory challenges and many key elements remain undefined, both domestic and international stakeholders are actively promoting the development and refinement of digital health standards to foster healthy industry growth and ensure that patients can use digital health products and services safely and effectively.

Against this backdrop, the 3rd China Digital Therapeutics Product Quality and Regulatory Symposium, together with the 2024 Annual Meeting of the Digital Therapeutics Professional Committee of the China Medical Devices Industry Association, will be held on October 24, 2024, at the GreenTree Oriental Hotel in Pudong, Shanghai, organized byDigital Therapeutics Professional Committee of the China Medical Device Industry AssociationHosted by,Shanghai Institute for Medical Device TestingOrganizer,Ministry of Education Innovation Scientific Instrument Engineering Research CenterCo-organized by,Changchun GeneScience Pharmaceuticals Co., Ltd., Chongqing Dongmaicheng Technology Co., Ltd. (VCBeat), Hangzhou Zhilan Health Co., Ltd., Viatris Pharmaceuticals Co., Ltd., ResMed (Beijing) Trading Co., Ltd., Shanghai TeHuofen Intelligent Technology Co., Ltd., Suzhou Yiduoyun Health Co., Ltd., Abbott Trading (Shanghai) Co., Ltd.Joint support.

(Scan the QR code to register for free)

We will conduct an in-depth analysis of the overall development and changes in the digital health sector in 2024, exploring the current state of digital therapeutics (DTx) development both domestically and internationally, as well as the evolving trends in DTx standards and regulations and the challenges faced. We aim to provide new insights and opportunities for the entire industry.

Highlight 1:Industry Insights from a Cutting-Edge Perspective

This conference will feature in-depth discussions on global standards for digital therapeutics (DTx), regulatory policies, and new pathways for DTx implementation. It will not only address current hot topics in the field of digital therapeutics but also focus on the challenges facing the industry and the direction of its future development. Attendees will have the opportunity to gain first-hand insights and professional analysis from industry experts, regulatory specialists, and business leaders.

Highlight 2: The First Review Meeting for the Group Standard on Digital Therapeutics in China

During the conference, we will witness the standard review meeting for China’s first group standard on digital therapeutics, “Special Technical Requirements for Software for Respiratory Function Data Monitoring and Analysis.” This milestone marks a solid step forward in China’s standardization efforts in the field of digital therapeutics and holds significant importance for promoting the industry’s standardized and international development. To further drive innovative development in the digital therapeutics industry, the conference will also launch the call for proposals and release of group standards by the Digital Therapeutics Professional Committee of the China Association for Medical Device Industry (CAMDI) for 2025, encouraging more enterprises and research institutions to participate in standard-setting and jointly promote the healthy development of the industry.

HighlightsThree：Digital TherapeuticsPractical Experience Sharing

Leading Industry Experts Share Progress and Implementation of Typical Digital Therapeutics Products: Using Their Own Companies as Case Studies, They Will Discuss Practical Experience in Product Development, Market Promotion, and Patient Acceptance. These Valuable First-Hand Insights Will Provide Attendees with Practical References and Inspiration.

Highlight 4:VerticalIndustryCooperation and Exchange Platform

This conference will bring together leaders from the China Association for Medical Devices Industry, experts from the Shanghai Institute for Medical Device Testing, leaders from the Center for Medical Device Evaluation, as well as experts in international standards, assessment, and notified bodies, representatives from relevant research institutions, and leading entrepreneurs in the field of digital therapeutics. It provides attendees with a valuable opportunity to connect with top talent in the industry and expand their business collaboration networks.

We sincerely invite every colleague passionate about digital therapeutics to join this grand event. Let us work hand in hand to confront challenges, seize opportunities, and drive the digital therapeutics industry toward a healthier, more standardized, and innovative future. Register now and join us on October 24, 2024, at the GreenTree Oriental Hotel Pudong Shanghai, where we will together usher in a new chapter for digital therapeutics and contribute to the advancement of the global healthcare industry!

(Scan the QR code to register for free)